Drug recall · February 27, 2013
Hydrocodone Bitartrate and Acetaminophen Tablets recall
Why: Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg; 100 Tablets (5 x 20), 5 cards each containing 20 blistered tablets per carton, Rx only; Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, Pkg by & Distributed by UDL Laboratories, Inc., Rockford, IL 61103; NDC 51079-254-21.
- Lots / codes
Lot #: 3037841, 3040859, 3042573, Exp 12/13
- Quantity
- 3,407 cartons
- Company
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL
- Distribution
- Nationwide
- Initiated
- December 14, 2012 · Voluntary: Firm initiated
- Classified
- February 15, 2013
- Reported
- February 27, 2013
- Ended
- August 9, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrocodone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.